Speaker Series
The speaker series attracts top-tier participants to our research community to share their experiences and discuss relevant topics of interest to entrepreneurs. These speakers are chosen from a broad range of expertise. To date our program has invited private investors, company CEOs, professionals from the pharma and biotech sector and seasoned entrepreneurs. Informal receptions are organized after talks to encourage networking within our community.
CRG Biobusiness School 2025
CRG Biobusiness School - 10th edition
5th to 9th May 2025
The Annual CRG BioBusiness School 2025 is a highly interactive, activity-driven learning process that takes scientists through a concentrated entrepreneurial immersion experience, aiming to instil an entrepreneurial mindset. It's designed to ignite the ability to convert lab ideas into business ones.
The core of the program takes participants through the venture building process in small groups of participants, supported by knowledge exchange with entrepreneurs and business experts. It culminates in a pitch event. The online interactive workshop provides valuable resources such as business templates, educational material, and a communication channel to capture and maximise the training outcome.
Participants benefits
You will benefit from building an entrepreneurial skillset that will give you the capacity and confidence to pinpoint the added commercial value of your research as well as to envision the creation of your own business. Independently of pursuance of the entrepreneurial path, the skills acquired throughout the course will confer participants with an advantage in the job market as these are greatly sought-after skills by the corporate, NGOs and public sector. The online format of the program widens the networking opportunities with national and international fellows, allowing you to establish bonds with other participants and invited speakers. Besides work, there will also be fun activities to keep the group stimulated and engaged.
Expectations from participants
The CRG BioBusiness School is a rewarding, exciting and intense program. We expect attendees to be fully engaged throughout the course, which includes 1 to 1.5 hours of additional knowledge dives in the evenings. There will also be an Innovation Knowledge Launchpad to be completed 2 weeks before the course starts.
Target audience
The workshop is tailored for researchers and management personnel working in life sciences.
Working style
The workshop will be highly interactive, with plenty of small group activities, plenary discussions, teaching dialogues, and project pitching training supported by the Mashauri learning platform.
Facilitator
Simon Gifford,...
CRG Entrepreneurship Week 2024
The CRG Entrepreneurship Week is an annual event that brings together budding entrepreneurs, industry leaders, and seasoned professionals to foster innovation and entrepreneurship. This year’s edition we will have talks by:
The sessions below are open to the CRG community only.
You can join the sessions by clicking on this link.
July 1, 2024
10:00 h
Miquel Vila-Perelló – CEO of SpliceBio
"The Scientist's Journey"
July 2, 2024
12:00 h
Marina Rigau – CEO of Mimark
"Meet the Entrepreneur"
July 3, 2024
12:00 h
Daniel Oliver – Partner at Capital Cell
"Meet the Investor"
July 4, 2024
11:00 h
Héctor Pérez- VP at Ability Pharma
"Into the Clinical Path"
CRG Entrepreneurship Week 2023
Once again, we celebrate the CRG Entrepreneurship Week, a time to meet and discuss with innovators and the entrepreneurship community, who dream big and inspire others to bring their ideas to life while driving socio-economic growth and welfare.
Targeting students, researchers, alumni, mentors, start-ups, industry, investors and other innovation partners.
The sessions below are open to the CRG community only.
You can join the sessions by clicking on this link.
April 24, 2023
10:30 h
Evan Floden, Seqera Labs
"The Scientist's Journey"
April 25, 2023
12:00 h
Joan Perelló, Sanifit
"Meet the Entrepreneur"
April 27, 2023
09:30 h
Malcolm Bain, Across Legal SLP
"Software Protection"
April 27, 2023
14:00 h
Gabor Heltovics, NLC Ventures
"Meet the Venture Builder"
TBDO Sessions Malcolm Bain
14/09/202212:00473.10TBDO SessionsMalcolm BainAcross LegalLicensing research software: options and challenges.Host: Sanz Molinero, Ana IsabelAbstract:Malcolm is an English solicitor and Spanish abogado. He has worked as an Information Technology and Intellectual Property lawyer over the last 20 years, with a specialisation in technology licensing, open source software and content, technology transfer and privacy.
In 2006, together with his partner Manuel Martínez, he founded his own firm “id-law partners” as a boutique specialized in IP and ICT. In May 2018, both incorporated this firm into Across Legal. In addition to his professional activity advising entrepreneurs, private companies, public administrations and open source projects, Malcolm is a member of the Free Software Foundation Europe and ASTP, associate professor of law at the University of Barcelona, ¿¿mentor in Tecniospring Industry and other programs for entrepreneurs and frequent speaker at conferences and seminars in the field of ICTs and entrepreneurship in the digital world.
Cell therapy in regenerative medicine from an industrial focus
On initiative of the TBDO, Dr. Miguel Mulet will provide an overview of cell therapy in regenerative medicine from an industrial focus and how this field illustrates particularly well, the challenges and risks of the trip from science to product during PRBB-CRG Session of Friday April 29th 2016 from 12:00-13:00. In this overview, he will touch various aspects:
- Cell therapy as a pharmaceutical product.
- How Mechanism of Action has been a moving target in parallel with product development.
- The intellectual property challenge of protecting inventions involving cells.
- Adapting biologics regulation to cell therapy.
- The long path of clinical development.
- Moving from a laboratory craft to industrial manufacturing.
- Commercialization and Market Access.
Miguel Mulet is Director of Strategy and New Projects in TiGenix, which is a leading European cell therapy company. His primary role at TiGenix is focused on aligning the functions that drive the cell therapy pipeline in Crohn’s Disease and Acute Myocardial Infarct. In addition, and besides business development activities to broaden the current pipeline, he is in charge of advancing the market readiness of the current platforms through implementation of new technologies and process improvement initiatives.